{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:12:23Z","timestamp":1659057143496},"reference-count":10,"publisher":"Societas Neurologica Japonica","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.843","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T23:06:42Z","timestamp":1384297602000},"page":"843-847","source":"Crossref","is-referenced-by-count":2,"title":["Ineffective mefloquine therapy in progressive multifocal leukoencephalopathy complicated with malignant lymphoma: finding and usefulness of susceptibility-weighted imaging"],"prefix":"10.5692","volume":"53","author":[{"given":"Aya","family":"Morimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Yukitake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kishida S, Tanaka K. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med 2010;49:2509-2513.","DOI":"10.2169\/internalmedicine.49.3227"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lummel N, Boeckh-Behrens T, Schoepf V, et al. Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology 2011;53:311-317.","DOI":"10.1007\/s00234-010-0736-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 2009;53:1840-1849.","DOI":"10.1128\/AAC.01614-08"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Naito K, Ueno H, Sekine M, et al. Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study. Intern Med 2012;51:205-209.","DOI":"10.2169\/internalmedicine.51.6253"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Beppu M, Kawamoto M, Nukuzuma S, et al. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med 2012;51:1245-1247.","DOI":"10.2169\/internalmedicine.51.6810"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hirayama M, Nosaki Y, Matsui K, et al. Efficacy of mefloquine to progressive multifocal leukoencephalopathy initially presented with parkinsonism. Clin Neurol Neurosurg 2012;114:728-731.","DOI":"10.1016\/j.clineuro.2011.12.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nevin RL. Pharmacokinetic considerations in the repositioning of mefloquine for treatment of progressive multifocal leukoencephalopathy. Clin Neurol Neurosurg 2012;114:1204-1205.","DOI":"10.1016\/j.clineuro.2012.02.046"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nevin RL. Neuropharmacokinetic heterogeneity of mefloquine in the treatment of progressive multifocal leukoencephalopathy. Intern Med 2012;51:2257.","DOI":"10.2169\/internalmedicine.51.7631"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kobayashi Z, Akaza M, Numasawa Y, et al. Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection. J Neurol Sci 2013;324:190-194.","DOI":"10.1016\/j.jns.2012.11.004"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u8a3a\u65ad\u306b\u78c1\u5316\u7387\u5f37\u8abf\u753b\u50cf\u304c\u6709\u7528\u3067\uff0c\u30e1\u30d5\u30ed\u30ad\u30f3\u6295\u4e0e\u306b\u3066\u6539\u5584\u3092\u307f\u3068\u3081\u306a\u304b\u3063\u305f\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u5408\u4f75\u9032\u884c\u6027\u591a\u5de3\u6027\u767d\u8cea\u8133\u75c7\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T17:19:12Z","timestamp":1564679952000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/53.843?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.843","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}